Evidence suggests that glutathione therapy can improve cognitive impairment and also function in preventive capacity.
Glutathione (GSH) is a major antioxidant used by the body to prevent cellular and tissue damage associated with cognitive impairment. Studies suggest the depletion of GSH in the hippocampal regions in mild cognitive impairment (MCI) and AD patients compared to healthy old subjects.